The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The psoriatic arthritis treatment market has experienced robust growth in recent years, driven by various factors such as increased diagnosis, rising prevalence of psoriatic arthritis, and expanding treatment options. This blog explores the market dynamics and emerging trends shaping the landscape.

Market Growth and Projections

• The market size surged from $10.93 billion in 2023 to $12 billion in 2024, with a CAGR of 9.8%.
• Forecasts indicate further growth, reaching $17.16 billion by 2028, driven by personalized medicine and emerging biologics.

Surging Prevalence Of Psoriasis And Psoriatic Arthritis

• Psoriasis and psoriatic arthritis are inflammatory disorders affecting millions globally.
• The incidence of psoriatic arthritis is approximately 30% among psoriasis patients.
• Major companies in the market include AbbVie Inc., Amgen Astellas BioPharma, Johnson & Johnson, and more.

View More On The Psoriatic Arthritis Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Innovative Jak Inhibitors Transform Treatment

• Janus kinase (JAK) inhibitors represent a novel approach to treating psoriatic arthritis.
• Drugs like tofacitinib, baricitinib, and upadacitinib offer promising results in managing the condition.
• Takeda Pharmaceutical’s acquisition of Nimbus Therapeutics strengthens its position in the market.

Takeda Pharmaceutical Bolsters Psoriatic Arthritis Treatment Portfolio

• Takeda’s acquisition of Nimbus Therapeutics enhances its product line in psoriatic arthritis treatment.
• Nimbus Therapeutics, a US-based biotech company, specializes in developing drugs for psoriatic arthritis treatment.

Market Segmentation The psoriatic arthritis treatment market is segmented based on:

1. Drug Class: NSAIDs, DMARDs, Biologics, and others
2. Route of Administration: Oral, Parenteral, Topical
3. Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Insights

• North America dominated the psoriatic arthritis treatment market in 2023.

Conclusion The psoriatic arthritis treatment market is witnessing significant growth driven by increased awareness, expanding treatment options, and strategic acquisitions. Innovations like JAK inhibitors offer new hope for patients, while companies continue to invest in research and development to address evolving treatment needs. As the market evolves, collaboration and innovation will play pivotal roles in improving patient outcomes and reshaping the treatment landscape.

Request A Sample Of The Global Psoriatic Arthritis Treatment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3458&type=smp